Literature DB >> 13199319

Bacterial resistance to isoniazid and marsilid in treatment of pulmonary tuberculosis; results of trials.

C M OGILVIE.   

Abstract

Entities:  

Keywords:  MYCOBACTERIUM TUBERCULOSIS/effect of drugs on; NICOTINIC ACID ISOMERS/therapeutic use; TUBERCULOSIS, PULMONARY/therapy

Mesh：

Substances：

Year:  1954        PMID： 13199319      PMCID： PMC2079491          DOI： 10.1136/bmj.2.4892.829

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  8 in total

1.  Tubercle bacilli resistant to isoniazid; virulence and response to treatment with isoniazid in guinea-pigs.

Authors:  D A MITCHISON
Journal:  Br Med J       Date:  1954-01-16

2.  Isoniazid and its isopropyl derivative in the therapy of tuberculosis in humans: comparative therapeutic and toxicologic properties.

Authors:  E H ROBITZEK; I J SELIKOFF; E MAMLOK; A TENDLAU
Journal:  Dis Chest       Date:  1953-01

3.  Isoniazid in pulmonary tuberculosis; its use with and without streptomycin.

Authors:  C L JOINER; K S MACLEAN; E K PRITCHARD; K ANDERSON; M B KING; P COLLARD; R KNOX
Journal:  Lancet       Date:  1952-11-01       Impact factor: 79.321

4.  [Resistance of Mycobacterium tuberculosis to isonicotinic acid hydrazide].

Authors:  V NITTI
Journal:  Arch Tisiol Mal Appar Respir       Date:  1952-09

5.  Isoniazid-resistant strains of tubercle bacili; their development and stability.

Authors:  M BARNETT; S R M BUSHBY; D A MITCHISON
Journal:  Lancet       Date:  1953-02-14       Impact factor: 79.321

6.  [The regression of resistance to isonicotinic acid hydrazide of Koch's bacillus after cessation of treatment].

Authors:  G A NIGOGHOSSIAN
Journal:  Schweiz Med Wochenschr       Date:  1953-02-28

7.  Antituberculous properties of hydrazines of isonicotinic acid (rimifon, marsilid).

Authors:  W STEENKEN; E WOLINSKY
Journal:  Am Rev Tuberc       Date:  1952-04

8.  In vitro studies on isonicotinic acid hydrazide.

Authors:  F PANSY; H STANDER; R DONOVICK
Journal:  Am Rev Tuberc       Date:  1952-06
  8 in total
  2 in total

1.  The clinical significance of positive cultures and of isoniazid-resistant tubercle bacilli during the treatment of pulmonary tuberculosis; report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council.

Authors:  W FOX; I SUTHERLAND
Journal:  Thorax       Date:  1955-06       Impact factor: 9.139

Review 2.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.